PinnyPeptide

Kisspeptin-10 vs Testagen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Kisspeptin-10

Sexual Health

Master upstream regulator of the reproductive axis — the GnRH releaser.

Peptide B

Testagen

Bioregulators

Khavinson short peptide bioregulator targeting testicular tissue.

Typical vial

5 mg

Typical dose

50-200 mcg

Half-life

~3-4 minutes (plasma)

FDA status

Not FDA approved as a therapeutic.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Kisspeptin-10 effects

  • Triggers GnRH pulse from hypothalamus
  • Stimulates LH and FSH release from pituitary
  • Indirectly raises testosterone (men) or estrogen (women)
  • Triggers egg maturation in IVF protocols
  • May increase libido and sexual arousal
  • Increases sexual-stimulus brain activation

Testagen effects

  • Reported support of Leydig cell testosterone production
  • Possible improvement in sperm parameters
  • Support of overall reproductive function
  • Anti-inflammatory effects in testicular tissue
  • Modulation of testicular gene expression

Kisspeptin-10 side effects

  • Generally well-tolerated at single doses
  • Headache (uncommon)
  • Theoretical: GnRH-axis desensitization with chronic dosing
  • Possible flushing or warmth sensation
  • Limited long-term safety data

Testagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proper hypogonadism evaluation

Kisspeptin-10 dosing ranges

Libido / HPG axis stimulation

50-200 mcg · Once or twice daily (SubQ) · Cycle-based, 2-4 weeks per cycle

IVF trigger (clinical, IV)

6.4-12.8 nmol/kg · Single dose 36 hours pre-collection · One-time

Testagen dosing ranges

Reproductive support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Kisspeptin-10 vs Testagen — common questions

What is the difference between Kisspeptin-10 and Testagen?

Kisspeptin-10: Master upstream regulator of the reproductive axis — the GnRH releaser. Typical dose 50-200 mcg. Testagen: Khavinson short peptide bioregulator targeting testicular tissue. Typical dose 1,000-5,000 mcg. Both fall under the Sexual Health and Bioregulators categories.

Can you stack Kisspeptin-10 and Testagen?

Stacking Kisspeptin-10 with Testagen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Kisspeptin-10 or Testagen?

Kisspeptin-10 is typically dosed: Once or twice daily (SubQ) for Libido / HPG axis stimulation; Single dose 36 hours pre-collection for IVF trigger (clinical, IV). Testagen is typically dosed: Once daily (SubQ) or sublingual for Reproductive support.

Are Kisspeptin-10 and Testagen FDA approved?

Kisspeptin-10: Not FDA approved as a therapeutic. Testagen: Not FDA approved.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free